151 related articles for article (PubMed ID: 27166193)
1. Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.
Guan H; Xie L; Wirth T; Ushmorov A
Oncotarget; 2016 Jun; 7(24):36854-36864. PubMed ID: 27166193
[TBL] [Abstract][Full Text] [Related]
2. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
Bohle V; Döring C; Hansmann ML; Küppers R
Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
[TBL] [Abstract][Full Text] [Related]
3. Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.
Wein F; Otto T; Lambertz P; Fandrey J; Hansmann ML; Küppers R
Haematologica; 2015 Oct; 100(10):1320-6. PubMed ID: 26160878
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.
Renné C; Martin-Subero JI; Eickernjäger M; Hansmann ML; Küppers R; Siebert R; Bräuninger A
Am J Pathol; 2006 Aug; 169(2):655-64. PubMed ID: 16877363
[TBL] [Abstract][Full Text] [Related]
6. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
Mathas S; Janz M; Hummel F; Hummel M; Wollert-Wulf B; Lusatis S; Anagnostopoulos I; Lietz A; Sigvardsson M; Jundt F; Jöhrens K; Bommert K; Stein H; Dörken B
Nat Immunol; 2006 Feb; 7(2):207-15. PubMed ID: 16369535
[TBL] [Abstract][Full Text] [Related]
8. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
9. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.
Jundt F; Acikgöz O; Kwon SH; Schwarzer R; Anagnostopoulos I; Wiesner B; Mathas S; Hummel M; Stein H; Reichardt HM; Dörken B
Leukemia; 2008 Aug; 22(8):1587-94. PubMed ID: 18449208
[TBL] [Abstract][Full Text] [Related]
12. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of B lymphoid cells in human lymphoma pathogenesis.
Janz M; Dörken B; Mathas S
Cell Cycle; 2006 May; 5(10):1057-61. PubMed ID: 16687930
[TBL] [Abstract][Full Text] [Related]
14. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.
Vogel MJ; Xie L; Guan H; Tooze RM; Maier T; Kostezka U; Maier HJ; Holzmann K; Chan FC; Steidl C; Reichel JB; Weitzer CD; Gehringer F; Kick AB; Cesarman E; Roshal M; Gascoyne RD; Möller P; Wirth T; Ushmorov A
Blood; 2014 Nov; 124(20):3118-29. PubMed ID: 25232062
[TBL] [Abstract][Full Text] [Related]
15. Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma.
Paczkowska J; Soloch N; Bodnar M; Kiwerska K; Janiszewska J; Vogt J; Domanowska E; Martin-Subero JI; Ammerpohl O; Klapper W; Marszalek A; Siebert R; Giefing M
Br J Haematol; 2019 Apr; 185(1):79-88. PubMed ID: 30681722
[TBL] [Abstract][Full Text] [Related]
16. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of Hodgkin lymphoma.
Weniger MA; Küppers R
Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
[TBL] [Abstract][Full Text] [Related]
18. Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation.
Osswald CD; Xie L; Guan H; Herrmann F; Pick SM; Vogel MJ; Gehringer F; Chan FC; Steidl C; Wirth T; Ushmorov A
Blood; 2018 Apr; 131(14):1556-1567. PubMed ID: 29439954
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of the tumour B-cell phenotype in Hodgkin lymphoma.
Küppers R; Bräuninger A
Trends Immunol; 2006 May; 27(5):203-5. PubMed ID: 16563865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
